ScholarLens Back to search
2013•Shiyong yaowu yu linchuangRequires access

Study on nimodipine combined with sertraline in the treatment of depression with only vascular risk factors

Zhang Hui-ping

Open publisher page 0 citations

Abstract

Objective To explore the clinical efficacy of nimodipine combined with sertraline in the treatment of depression with only vascular risk factors.Methods Two hundred depression patients of our hospital from June 2009 to June 2012 were randomly divided into two groups.Patients in combination group were given nimodipine and sertraline,while patients in control group received only sertraline.HAMD and MMSE were used to evaluate the efficacy of the two groups.Results The scores of HAMD and MMSE of the two groups were improved after treatment(P0.05),and there were significant differences between the two groups.Conclusion Nimodipine combined with sertraline has better effect in the treatment of depression with only vascular risk factors.

About this research paper

What this paper is about

Objective To explore the clinical efficacy of nimodipine combined with sertraline in the treatment of depression with only vascular risk factors.Methods Two hundred depression patients of our hospital from June 2009 to June 2012 were randomly divided into two groups.Patients in combination group were given nimodipine and sertraline,while patients in control group received only sertraline.HAMD and MMSE were used to evaluate the efficacy of the two groups.Results The scores of HAMD and MMSE of the two groups were improved after treatment(P0.05),and there were significant differences between the two groups.Conclusion Nimodipine combined with sertraline has better effect in the treatment of depression with only vascular risk factors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical efficacy of nimodipine combined with sertraline in the treatment of depression with only vascular risk factors.Methods Two hundred depression patients of our hospital from June 2009 to June 2012 were randomly divided into two groups.Patients in combination group were given nimodipine and sertraline,while patients in control group received only sertraline.HAMD and MMSE were used to evaluate the efficacy of the two groups.Results The scores of HAMD and MMSE of the two groups were improved after treatment(P0.05),and there were significant differences between the two groups.Conclusion Nimodipine combined with sertraline has better effect in the treatment of depression with only vascular risk factors.

Key concepts: Nimodipine, Sertraline, Hamd, Depression (economics), Medicine, Internal medicine, Anesthesia, Significant difference

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Study on nimodipine combined with sertraline in the treatment of depression with only vascular risk factors — Research Paper | ScholarLens